What are the serum sodium cut‑offs for hypernatremia and how should hypernatremia be managed based on the patient’s volume status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypernatremia: Definition and Management Based on Volume Status

Hypernatremia is defined as serum sodium >145 mmol/L, and management depends critically on distinguishing between hypovolemic, euvolemic, and hypervolemic states, with correction rates never exceeding 10-12 mmol/L per 24 hours to prevent cerebral edema. 1, 2

Diagnostic Cut-offs

  • Mild hypernatremia: 145-150 mmol/L 2
  • Moderate hypernatremia: 150-160 mmol/L 2
  • Severe hypernatremia: >160 mmol/L 2
  • Life-threatening hypernatremia: >180-200 mmol/L (associated with extremely high mortality) 3

The initial serum sodium concentration and patient age are the most important prognostic indicators, with very young patients and those with lesser degrees of hypernatremia having better survival rates. 3

Initial Assessment Algorithm

Step 1: Determine Volume Status

Physical examination findings guide the differential diagnosis: 4, 5

  • Hypovolemic signs: Orthostatic hypotension, dry mucous membranes, decreased skin turgor, tachycardia, flat neck veins 5
  • Euvolemic signs: Normal blood pressure, normal skin turgor, no edema 5
  • Hypervolemic signs: Peripheral edema, jugular venous distention, pulmonary congestion, ascites 5

Step 2: Check Urine Osmolality

  • Urine osmolality >600-800 mOsm/kg: Indicates appropriate renal water conservation; suggests extrarenal water losses (GI losses, insensible losses, burns) 4, 5
  • Urine osmolality <300 mOsm/kg: Indicates impaired renal concentrating ability; suggests diabetes insipidus (central or nephrogenic) 4, 5

Management Based on Volume Status

Hypovolemic Hypernatremia (Most Common)

Replace both volume and free water deficit using hypotonic fluids: 2, 4

  • First-line fluid: 0.45% NaCl (half-normal saline) for moderate hypernatremia 2
  • Alternative: 0.18% NaCl or D5W for more severe hypernatremia requiring greater free water replacement 2
  • Initial rate: Calculate free water deficit using the formula: Free water deficit (L) = 0.6 × body weight (kg) × [(serum Na/140) - 1] 2
  • Avoid isotonic saline (0.9% NaCl): This will worsen hypernatremia in patients with renal concentrating defects 6

Euvolemic Hypernatremia (Diabetes Insipidus)

Central diabetes insipidus: 4, 5

  • Desmopressin (DDAVP): 1-4 mcg subcutaneously or IV every 12-24 hours 1, 5
  • Plus hypotonic fluid replacement: 0.45% NaCl or D5W to replace ongoing losses 1

Nephrogenic diabetes insipidus: 4, 5

  • Hypotonic fluids: Continuous administration to match excessive free water losses 6, 4
  • Thiazide diuretics: Paradoxically reduce urine output by inducing mild volume depletion 5
  • Amiloride: If lithium-induced nephrogenic DI 5

Hypervolemic Hypernatremia (Sodium Excess)

Remove excess sodium while providing free water: 2, 4

  • Loop diuretics (furosemide): To promote sodium excretion 2
  • Plus hypotonic fluid replacement: D5W or 0.45% NaCl 2
  • Hemodialysis: For severe cases or renal failure 1, 2

Critical Correction Rate Guidelines

For chronic hypernatremia (>48 hours duration): 1, 2

  • Maximum correction rate: 8-10 mmol/L per 24 hours 1
  • Preferred rate: 0.5 mmol/L per hour or 10-12 mmol/L per day 2
  • Rationale: Rapid correction causes cerebral edema due to osmotic shifts 1, 2

For acute hypernatremia (<24 hours duration): 1

  • Hemodialysis is an effective option to rapidly normalize serum sodium levels 1
  • However, even in acute cases, avoid drops >12 mmol/L per 24 hours when starting renal replacement therapy 1

Monitoring Protocol

  • Serum sodium: Every 2-4 hours during active correction 2
  • Urine output and osmolality: Every 4-6 hours 2
  • Neurological status: Continuous assessment for signs of cerebral edema (headache, confusion, seizures) 2
  • Volume status: Serial physical examinations 2

Special Clinical Scenarios

Patients with Renal Concentrating Defects

Nephrogenic diabetes insipidus patients require ongoing hypotonic fluid administration to match their excessive free water losses, and isotonic fluids will worsen hypernatremia. 6

Salt Intoxication

Surprisingly small amounts of salt can cause severe hypernatremia: 3

  • Ingestion of approximately 70-90 g of table salt (1,200-1,500 mEq sodium) can produce serum sodium >200 mmol/L 3
  • Mortality is extremely high with initial sodium >180-200 mmol/L 3
  • Treatment: Hypotonic fluid therapy to provide free water, but prognosis depends primarily on initial sodium level and patient age 3

Common Pitfalls to Avoid

  • Using isotonic saline in patients with impaired renal concentrating ability will exacerbate hypernatremia 6
  • Correcting chronic hypernatremia too rapidly (>10-12 mmol/L per day) causes cerebral edema 1, 2
  • Undercorrection or overcorrection are both associated with poor prognosis 2
  • Failing to address the underlying cause (stopping causative medications, treating diabetes insipidus, replacing ongoing losses) 4, 5
  • Inadequate monitoring during correction can lead to complications 2

References

Research

[Hypernatremia - Diagnostics and therapy].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2016

Research

Salt and Water: A Review of Hypernatremia.

Advances in kidney disease and health, 2023

Research

Diagnosis and treatment of hypernatremia.

Best practice & research. Clinical endocrinology & metabolism, 2016

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.